Key Insider Jack C. Bendheim Sells $8.0M in Shares Over Two Months
PAHC has more than doubled off its 52-week low of $17.17.
Summary
A major insider, Jack C. Bendheim, disclosed selling approximately $8.0 million worth of Phibro Animal Health Corporation shares over the last two months, signaling a reduction in his direct stake.
Key Events · Ownership and Investor Activity · PAHC
-
Significant Insider Sales
Jack C. Bendheim, a key insider and Class A Manager of BFI Co., LLC, reported selling 149,429 shares of Class A Common Stock.
-
Substantial Proceeds
The sales generated approximately $8.0 million in proceeds for the reporting persons.
-
Ongoing Stake
Despite the sales, Bendheim and BFI Co., LLC still beneficially own 19,591,914 shares, representing 48.3% of the total Class A Common Stock (assuming conversion of Class B shares).
-
Multi-Month Activity
The transactions occurred between February 20, 2026, and April 23, 2026, as detailed in Exhibit 3.
Analysis · PAHC · Life Sciences
Jack C. Bendheim, a significant insider and Class A Manager of BFI Co., LLC, has reported substantial sales of Phibro Animal Health Corporation stock. The sales, totaling approximately $8.0 million across 149,429 shares, occurred over the past two months. While these are not 10b5-1 pre-planned sales, they represent a notable reduction in direct holdings by a key individual with significant control over the company. Investors should monitor future insider activity for further insights into management's sentiment.
At the time of this filing, PAHC was trading at $54.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $17.17 to $60.08. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.